tiprankstipranks
ALX Oncology Holdings (ALXO)
NASDAQ:ALXO
US Market

ALX Oncology Holdings (ALXO) Income Statement

Compare
374 Followers

ALX Oncology Holdings Income Statement

Last quarter (Q3 2024), ALX Oncology Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, ALX Oncology Holdings's net income was $-30.71M. See ALX Oncology Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.18M$ 4.80M
Gross Profit
$ -836.00K$ -1.47M$ -736.00K$ 107.00K$ 436.00K
Operating Expenses
$ 170.28M$ 127.44M$ 83.56M$ 43.77M$ 19.62M
Depreciation and Amortization
$ 836.00K$ 1.47M$ 736.00K$ 202.00K$ 429.00K
EBITDA
$ -158.40M$ -121.95M$ -83.47M$ -43.46M$ -18.76M
Operating Income
$ -170.28M$ -127.44M$ -83.56M$ -43.66M$ -19.18M
Other Income/Expenses
$ 9.47M$ 4.02M$ 71.00K$ -1.84M$ -26.00K
Pretax Income
$ -160.81M$ -123.42M$ -83.48M$ -45.50M$ -19.21M
Net Income
$ -160.81M$ -123.48M$ -83.46M$ -45.74M$ -19.24M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -3.74$ -3.03$ -2.07$ -1.15$ -0.53
Diluted EPS
$ -3.74$ -3.03$ -2.07$ -1.15$ -0.53
Weighted Average Shares Outstanding
42.99M 40.70M 40.31M 39.84M 36.49M
Weighted Average Shares Outstanding (Diluted)
42.99M 40.70M 40.31M 39.84M 36.49M
Currency in USD

ALX Oncology Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis